News
Mallinckrodt Submits INDA For Synacthen Depot
Company will pursue an indication for the drug in treatment of Duchenne Muscular Dystrophy.Mallinckrodt plc a leading global specialty biopharmaceutical company, announced it has...
News
Pfizer Announces Final Results From Inotuzumab Ozogamicin Pivotal Phase 3 Study With Refractory Acute Lymphoblastic Leukemia
Pfizer Inc announced the publication of findings from the Phase 3 INO-VATE ALL study in the online issue of The New England Journal of...
Press Releases
ViiV Healthcare announces FDA approval to lower the weight limit for dolutegravir in children and adolescents living with HIV
ViiV Healthcare announced that the US FDA has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg oral tablets, reducing the...
News
Ironwood and Allergan Announce New Drug Application for 72 mcg Linaclotide Has Been Accepted for FDA Review
Ironwood Pharmaceuticals, Inc.and Allergan plc announced that the U.S. FDA has accepted for review the supplemental New Drug Application (sNDA) for the 72 mcg...
Press Releases
AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio
Agreement expands commercial reach for anaesthetics and supports the Company’s sharp focus on innovative new medicines in its three main therapy areas. ...
Press Releases
PCI Pharma Services’ Hay-on-Wye Site Launches New 3D Camera Technology from Scanware
PCI Pharma Services is installing specialist, innovative three-dimensional (3D) and high resolution color camera technology for product inspection and fill control on three of...
Industry Reports
Bristol-Myers Squibb to Announce Results for Second Quarter 2016 on July 28
Bristol-Myers Squibb Company will announce results for the second quarter of 2016 on Thursday, July 28, 2016. During a conference call at 10:30 a.m....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read